Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
12/2000
12/07/2000WO2000073337A1 Polymer conjugates of hedgehog proteins and uses
12/07/2000WO2000044392A3 Identification of specific differentially expressed mycobacterial antigens
12/07/2000CA2414214A1 Four-helical bundle protein zsig81
12/07/2000CA2378737A1 Adipocyte complement related protein homolog zacrp5
12/07/2000CA2376116A1 Promotion or inhibition of angiogenesis and cardiovascularization
12/07/2000CA2375700A1 Polymer conjugates of hedgehog proteins and uses
12/07/2000CA2375050A1 T-bet compositions and methods of use thereof
12/07/2000CA2374412A1 Secreted alpha-helical protein-31
12/07/2000CA2374391A1 Mammalian receptor proteins; related reagents and methods
12/07/2000CA2374387A1 Adipocyte complement related protein homolog zacrp7
12/07/2000CA2374369A1 Assays for caspase activity using green fluorescent proteins
12/07/2000CA2374133A1 Structural models for cytoplasmic domains of transmembrane receptors
12/07/2000CA2373915A1 Methods and compositions for inhibiting neoplastic cell growth
12/06/2000EP1056868A1 Human homolog of the drosophila protein 'fused'
12/06/2000EP0695352A4 Dna encoding cobra c3, cvf1, and cvf2
12/05/2000US6156888 Mixture of a carrier and a polynucleotide encoding a hybrid protein of a factor viii protein having an acidic region from a donor anticoagulant or antithrombotic protein replacing a region in the native protein
12/05/2000US6156887 Compositions and methods for the treatment and diagnosis of immune disorders
12/05/2000US6156878 Amino acid sequences; for antibodies, immunosuppressants, immunomodulators, immunotoxins, and diagnosis of related disorders
12/05/2000US6156495 Kit for detecting the presence of microorganism antigen in humans; for the development of vaccines against viral diseases
12/05/2000US6156314 Monoclonal antibodies
11/2000
11/30/2000WO2000071701A1 Method for generating split, non-transferable genes that are able to express an active protein product
11/30/2000WO2000071577A1 Meth1 and meth2 polynucleotides and polypeptides
11/30/2000WO2000071564A2 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071141A1 Modified factor viii
11/30/2000WO2000047611A3 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
11/30/2000WO2000047610A3 Method for altering undesirable immune responses to polypeptides
11/30/2000WO2000026380A9 Rotavirus subunit vaccine
11/30/2000WO2000025725A3 Functional antagonists of hedgehog activity
11/30/2000CA2382774A1 Meth1 and meth2 polynucleotides and polypeptides
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374497A1 Method for generating split, non-transferable genes that are able to express an active protein product
11/30/2000CA2371828A1 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
11/29/2000EP1054984A1 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
11/29/2000EP1054973A1 Antigen library immunization
11/29/2000EP1054969A2 Retinoblastoma protein complexes and retinoblastoma interacting proteins
11/29/2000EP1054899A2 AGENTS FOR TREATING HUMAN ILLNESSES BASED ON $g(b)-CATENIN, AND THE PRODUCTION AND USE THEREOF
11/29/2000EP1054683A1 Modified heat shock protein-antigenic peptide complex
11/29/2000EP0555205B1 Dna encoding a growth factor specific for epithelial cells
11/29/2000CN1275085A Cytolysis of target cell, reagent and composition for cytolysis and compound for preparing these reagents
11/28/2000US6153579 Crystallizable compositions comprising a hepatitis C virus NS3 protease domain/NS4A complex
11/28/2000US6153435 Nucleotide sequences coding hybrid envelope polypetides; for gene therapy
11/28/2000US6153430 Used as indicator of the presence of ovarian cancer tumor cells
11/28/2000US6153405 Nucleic acid which encodes a leader sequence from nisin and/or subtilin and a lantibiotic; for recombinant production of antibiotics
11/28/2000US6153377 Synthetic DNA derived recombinant HIV antigens
11/28/2000US6153189 Human TRK receptors and neurotrophic factor inhibitors
11/23/2000WO2000069913A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS
11/23/2000WO2000069911A1 Long lasting insulinotropic peptides
11/23/2000WO2000069888A1 Self-assembling biomolecular structures
11/23/2000WO2000069456A2 Adjuvant combination formulations
11/23/2000WO2000040615A3 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS
11/23/2000WO2000036092A3 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION
11/23/2000WO2000032221A3 Promotion or inhibition of angiogenesis and cardiovascularization
11/23/2000WO2000031124A3 Peptides that modulate the interaction of b class ephrins and pdz domains
11/23/2000WO2000028020A3 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor
11/23/2000WO2000028011A3 Fk506-based regulation of biological events
11/23/2000WO2000018881A3 Intein mediated peptide ligation
11/23/2000WO2000017369A3 Alzheimer's disease secretase
11/23/2000CA2767116A1 Adjuvant combination formulations
11/23/2000CA2623458A1 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
11/23/2000CA2501421A1 Long lasting exendin-4
11/23/2000CA2372200A1 Self-assembling biomolecular structures
11/22/2000EP1053351A1 Novel molecules of the tnf receptor superfamily and uses therefor
11/22/2000EP1053325A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
11/22/2000EP1053321A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
11/22/2000EP1053241A1 Novel dimerizing agents, their production and use
11/22/2000CN1274289A Compsns. comprising comjugates of stable, active, human ob protein with antibody FC chain and methods
11/21/2000US6150150 Human brain phosphodiesterase
11/21/2000US6150093 Unique associated Kaposi's sarcoma virus sequences and uses thereof
11/16/2000WO2000068416A2 Method for localising proteases which split substrates that are specifically connected by a membrane
11/16/2000WO2000068381A1 Cytokine receptor mouse zcytor10
11/16/2000WO2000068376A1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
11/16/2000WO2000068269A1 Constitutive chimeric receptors, and methods of use thereof
11/16/2000WO2000067793A1 Death domain containing receptor 4
11/16/2000WO2000067761A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000WO2000067697A2 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells
11/16/2000WO2000053633A3 Antibody and chemokine constructs that are directed to ccr5, and their use for treating autoimmune diseases
11/16/2000WO2000042179A3 Complex-forming proteins
11/16/2000WO2000036118A3 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE)
11/16/2000WO2000034784A9 Protein scaffolds for antibody mimics and other binding proteins
11/16/2000WO2000026370A3 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/16/2000WO2000026241A3 Novel compositions and methods of screening for t-cell and b-cell activation modulators
11/16/2000WO2000023464A3 Zinc finger binding domains for gnn
11/16/2000WO2000020448A3 Nlk1 -interacting proteins
11/16/2000WO2000007631A9 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response
11/16/2000WO2000006717A9 Improved transformation efficiency in phage display through modification of a coat protein
11/16/2000DE19920514A1 Methoden zur Auffindung von Proteasen, die spezifisch membrangebundene Substrate spalten Methods for the detection of proteases that cleave specific membrane-bound substrates
11/16/2000CA2374237A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000CA2373851A1 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells
11/16/2000CA2373063A1 Death domain containing receptor 4
11/16/2000CA2372837A1 Cytokine receptor mouse zcytor10
11/16/2000CA2372807A1 Constitutive chimeric receptors, and methods of use thereof
11/16/2000CA2370212A1 Methods of discovering proteases which specifically cleave membrane-bound substrates
11/15/2000EP1051489A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
11/14/2000US6147202 Nucleotide sequences coding erythrocyte proteins; for utilization in blood transfusions
11/14/2000US6146827 Detecting nucleic acid involved in g protein mediated signal transduction in a t helper cell sample
11/14/2000US6146635 System for the expression of heterologous antigens as fusion proteins
11/10/2000CA2307446A1 Complex for transferring an anionic substance of interest into a cell
11/09/2000WO2000066755A2 Pesticidal fusions
11/09/2000WO2000066739A2 Chlamydia antigens and corresponding dna fragments and uses thereof
1 ... 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 ... 295